tirzepatide idiopathic intracranial hypertension Proposed pathophysiological mechanisms underlying IIH and the target Living with Idiopathic Intracranial Hypertension

If you are experiencing diarrhea (less common than constipation but it happens), increase even further

So, if youre not losing weight on tirzepatide, it may be worth taking a closer look at other treatments in your regimen

Gastrointestinal effects dominate: nausea (1722%), diarrhea (1316%), vomiting (610%), decreased appetite (79%), and indigestion (~7%)

The timing of discontinuation should balance two competing considerations: allowing adequate medication clearance while maintaining the metabolic benefits achieved through weight loss

The comparison between semaglutide and tirzepatide side effects also shows important differences

The SURPASS trials show significant A1c and metabolic improvements at therapeutic doses of 515 mg